Welcome to Pharmaceutical Markets.com

Latest News

• J&J pays $1B for Elan stake

  J&J will take an 18.4 per cent stake drug developer Elan with a $1 billion investment, AP reports. [FULL STORY]

• FDA orders 'black box' warnings on Pfizer and GSK anti-smoking drugs

  US health officials on Wednesday ordered Pfizer and GSK to add strong 'black box' warnings on their anti-smoking drugs to highlight the risk of serious mental health problems, including suicidal thoughts, Reuters reports. [FULL STORY]

• Pfizer and Eisai will not appeal NICE's Alzheimer's decision

  Pfizer and Eisai have decided that they will not lodge an appeal against the National Institute for Health and Clinical Excellence’s (NICE) current guidance for the treatment of Alzheimer's disease, pharmatimes.com reports. [FULL STORY]

• GSK buys Bristol-Myers' generic drugs in Middle East

  GSK expanded its emerging markets footprint on Thursday by buying Bristol-Myers' branded generics drugs business in Lebanon, Jordan, Syria, Libya and Yemen for $23.2 million, Reuters reports. [FULL STORY]

• FDA reviewing safety of Sanofi-Aventis' Lantus

  The FDA said on Wednesday that it is reviewing data on the safety of Lantus, a synthetic insulin made by Sanofi-Aventis, AP reports. [FULL STORY]